OTCM
DYSL
Market cap27mUSD
May 08, Last price
1.80USD
Name
Dynasil Corporation of America
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dynasil Corporation of America, a global entity, specializes in the invention, production, and sale of advanced detection, sensing, and analysis technologies, along with high-quality optical components. Its market reach extends throughout the United States, Asia, Europe, and other international regions. The company's operations are divided into three core segments: Optics, Innovation and Development, and Biomedical. The Optics division furnishes synthetic crystals, specialized optical materials, various components, and coatings. These are crucial for a diverse range of applications such as baggage scanners, medical imaging equipment, precision optical instruments, lasers, analytical devices, automotive parts, semiconductor and electronic devices, aerospace components, and advertising displays, serving sectors like healthcare, industrial manufacturing, and homeland security/defense. Through its Innovation and Development segment, Dynasil is at the forefront of creating novel materials, sophisticated sensors, and experimental instruments designed to detect or measure radiation, light, magnetism, or sound, with applications spanning security, medical, and industrial fields. The Biomedical segment is dedicated to the advancement of tissue sealant products. Dynasil distributes its offerings through its own direct sales and marketing personnel, complemented by a network of manufacturer's representatives and external distributors. Founded in 1960, Dynasil Corporation of America is headquartered in Newton, Massachusetts.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||